Video

Dr Peter P. Yu Talks About the Importance of Patient-Centered Oncology Care

The American Journal of Managed Care's Patient-Centered Oncology Care meeting is an important event for anyone interested in "crossing the chasm" that appears between providers and the rest of the healthcare world, explained Peter P. Yu, MD, president of the American Society of Clinical Oncology.

The American Journal of Managed Care's Patient-Centered Oncology Care meeting is an important event for anyone interested in "crossing the chasm" that appears between providers and the rest of the healthcare world, including payers and hospital administrators, explained Peter P. Yu, MD, president of the American Society of Clinical Oncology, and the keynote speaker from Patient-Centered Oncology Care 2014.

Related Videos
Bridgette J. Picou, LVN, ACLPN, The Well Project
Mia Moore, PhD, Fred Hutch Cancer Center
rachel rohaidy
Steven Daniel Daveluy, MD, FAAD
Shawn Kwatra, MD, FAAD
Dr Xin Hu
Elizabeth Jones, MD, FAAD.
Tiffany Meng, PharmD, oncology pharmacist with UCSF Health
Brittany Craiglow, MD, FAAD
Related Content
Newer technology may play an important role in aiding early skin cancer diagnosis, new research suggests. | Image credit: InsideCreativeHouse - stock.adobe.com
March 11th 2025

AI, Other Technologies May Help Narrow Gender Disparities in Melanoma

Jared Kaltwasser
Men with melanoma tend to be diagnosed later and have worse outcomes. Artificial intelligence can help change that, a review suggests.
Managed Care Cast Logo
February 25th 2025

Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care

Pearl Steinzor Arthur L. Jenkins III, MD, FACS
On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Subcutaneous drug administration | Image: FreePik
March 9th 2025

With Sub-Q Immunotherapy Coming, “Patient Preference Has to Be the Key”

Mary Caffrey
An oncologist from Atrium Health outlines how saving time administering immunotherapy could have far-reaching benefits.
Telemedicine’s Evolution and Expanding Access to Obesity, Specialty Care
February 11th 2025

Telemedicine’s Evolution and Expanding Access to Obesity, Specialty Care

Maggie L. Shaw George Jones
George Jones of UpScript Health discusses telemedicine's evolution from basic e-prescribing to real-time video consultations, expanding treatment beyond primary care.
Revakinagene taroretcel-lwey is the first and only FDA-approved treatment available for MacTel. | Image credit: wladimir1804 - stock.adobe.com
March 7th 2025

FDA Approves Revakinagene Taroretcel for Macular Telangiectasia Type 2

Rose McNulty
Revakinagene taroretcel-lwey (Encelto; Neurotech), an allogeneic encapsulated cell-based gene therapy, is the first therapy to be approved for macular telangiectasia type 2.
AJMC
March 7th 2025

Demographic Disparities in Video Visit Telemetry: Understanding Telemedicine Utilization

Daniel Stein, MS Mark L. Moubarek, MD Jeffrey Fine, MPH Jeffery Wajda, DO Mark Avdalovic, MD
A stratified demographics analysis of video visit telemetry data reveals that age older than 65 years and African American/Black race are associated with higher video visit failure rates, whereas language, sex, and ethnicity are not.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo